FDA Drug Application (204708) for MIRVASO by GALDERMA LABS LP

Back to FDA Applications sponsored by GALDERMA LABS LP

Application Number204708
Product Number001
FormGEL;TOPICAL
DosageEQ 0.33% BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMIRVASO
Active IngredientBRIMONIDINE TARTRATE

Active IngredientCount
List of drugs with Active Ingredient BRIMONIDINE TARTRATE8


Back to FDA Applications sponsored by GALDERMA LABS LP